Richard Kelly – Is it possible to discontinue anticoagulation in patients with PNH?
VJHemOnc shared on X:
“Is it possible to discontinue anticoagulation in patients with PNH?
Dr Richard Kelly commented on this in a recent interview at IPIG2025, which you can watch.”
Watch the full interview on VJHemOnc to explore whether anticoagulation withdrawal is feasible—and for whom
Can anticoagulation safely be discontinued in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)? This pressing clinical question was recently addressed by Dr. Richard Kelly during an interview at the International PNH Interest Group Congress (IPIG 2025). As treatment paradigms evolve with the advent of complement inhibitors, the traditional rationale for long-term anticoagulation in PNH patients is being actively re-evaluated”.
Dr. Kelly shares insights into emerging data, individualized risk stratification, and the potential for safe de-escalation of anticoagulant therapy in select patients with controlled hemolysis and no history of thrombosis.
You can read a wide variety of new posts in Hemostasis Today.
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage
-
Oct 9, 2026, 13:07The Rebalanced Patient: New Therapies and New Thrombotic Risks in Hemophilia
-
Oct 9, 2026, 12:48Santiago Cepeda Chafla: CereBleed Simplifies Brain Hemorrhage Assessment
-
Oct 9, 2026, 12:34Abdul Muqtadir Abbasi: Pancytopenia Is a Finding, Not a Diagnosis
-
Oct 9, 2026, 12:24Mercy Lung’aho: When Diet Quality and Nutritional Biomarkers Tell Different Stories